Diseases, Free Full-Text

Por um escritor misterioso
Last updated 10 maio 2024
Diseases, Free Full-Text
(1) Introduction: Traumatic brain injury (TBI) is a leading cause of injury and mortality worldwide, carrying an estimated cost of $38 billion in the United States alone. Neutrophil to lymphocyte ratio (NLR) has been investigated as a standardized biomarker that can be used to predict outcomes of TBI. The aim of this review was to determine the prognostic utility of NLR among patients admitted for TBI. (2) Methods: A literature search was conducted in PubMed, Scopus, and Web of Science in November 2022 to retrieve articles regarding the use of neutrophil to lymphocyte ratio (NLR) as a prognostic measure in traumatic brain injury (TBI) patients. Inclusion criteria included studies reporting outcomes of TBI patients with associated NLR values. Exclusion criteria were studies reporting only non-primary data, those insufficiently disaggregated to extract NLR data, and non-English or cadaveric studies. The Newcastle-Ottawa Scale was utilized to assess for the presence of bias in included studies. (3) Results: Following the final study selection 19 articles were included for quantitative and qualitative analysis. The average age was 46.25 years. Of the 7750 patients, 73% were male. Average GCS at presentation was 10.51. There was no significant difference in the NLR between surgical vs. non-surgical cohorts (SMD 2.41 95% CI −1.82 to 6.63, p = 0.264). There was no significant difference in the NLR between bleeding vs. non-bleeding cohorts (SMD 4.84 95% CI −0.26 to 9.93, p = 0.0627). There was a significant increase in the NLR between favorable vs. non-favorable cohorts (SMD 1.31 95% CI 0.33 to 2.29, p = 0.0090). (4) Conclusions: Our study found that NLR was only significantly predictive for adverse outcomes in TBI patients and not surgical treatment or intracranial hemorrhage, making it nonetheless an affordable alternative for physicians to assess patient prognosis.
Diseases, Free Full-Text
COVID Resources Maryland Developmental Disabilities Council
Diseases, Free Full-Text
Empagliflozin in Patients with Chronic Kidney Disease
Diseases, Free Full-Text
Celiac Disease: Symptoms, Testing, Treatment & Research
Diseases, Free Full-Text
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
Diseases, Free Full-Text
Infectious Diseases of Poverty
Diseases, Free Full-Text
National Organization for Rare Disorders
Diseases, Free Full-Text
Foot and mouth disease - WOAH - World Organisation for Animal Health
Diseases, Free Full-Text
A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease - ScienceDirect
Diseases, Free Full-Text
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 - The Lancet
Diseases, Free Full-Text
8 Steps to Prevent Heart Disease and Stroke Infographic
Diseases, Free Full-Text
RePub, Erasmus University Repository: The rise and fall of diseases: reflections on the history of population health in Europe since ca. 1700
Diseases, Free Full-Text
International Classification of Diseases (ICD)

© 2014-2024 ambarfurniture.com. All rights reserved.